Thursday, December 1, 2022 episode artwork

EPISODE · Dec 1, 2022 · 6 MIN

Thursday, December 1, 2022

from The Gist Healthcare Podcast

A new Alzheimer’s drug has shown promise in slowing cognitive decline in Phase 3 clinical trials but concerns remain about its safety. Former MetroHealth CEO Akram Boutros is suing the hospital system and its board of trustees for violating Ohio’s Open Meetings Act--and its own bylaws--when it fired him. And Twitter has quietly stopped enforcing its COVID-19 misinformation policy. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Dec 1, 2022

Embed this episode

NOW PLAYING

Thursday, December 1, 2022

0:00 6:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 6 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on December 1, 2022.

Can I download this The Gist Healthcare Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!